Allergan's cash-use plan, pipeline could add to share run

NEW YORK, Aug 4 (Reuters) - Four months after the collapse

of its deal to be bought by Pfizer, Allergan plc

has a $33 billion war chest, a pipeline of experimental drugs

that some investors view as...

Read more